Periprocedural bridging of anticoagulation.
When deciding to preoperatively interrupt--and potentially substitute--a chronic treatment with antithrombotics or not, the surgical or anesthetic bleeding risk of continuing or substituting treatment should be balanced against the risk of thrombosis in case treatment is not interrupted or substituted. The decision will primarily be based upon the initial indication to antithrombotic treatment and the nature of the planned procedure.
Department of Anaesthesiology, University Hospitals Leuven, Belgium.
E
E
Vandermeulen
P
P
Verhamme
D000765:Anesthesia, Conduction; D000925:Anticoagulants / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D013923:Thromboembolism / Q000188:drug therapy; D014812:Vitamin K / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014812:Vitamin K